LEUKEMIA Flashcards

1
Q

a malignant disease characterized by unregulated proliferation of one cell type.

A

LEUKEMIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

leukemia may involve any of the ____ or a ____ common to several cell lines

A

cell lines; stem cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

leukemias 2 major groups

A

chronic and acute leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

the onset is insidious, the disease is usually less aggressive, and the cells involved are usually more mature cells

A

chronic leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

the onset is usually rapid, the disease is very aggressive, and the cells involved are usually poorly differentiated with many blasts.

A

acute leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Both acute and chronic leukemias are further classified according to the prominent cell line involved in the expansion:

A

If the prominent cell line is of the myeloid series it is a myelocytic leukemia (sometimes also called granulocytic)

If the prominent cell line is of the lymphoid series it is a lymphocytic leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

four basic types of leukemia

A

Acute myelocytic leukemia
Acute lymphocytic leukemia
Chronic myelocytic leukemia
Chronic lymphocytic leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

type of leukemia that includes myeloblastic, promyelocytic, monocytic, myelomonocytic, erythrocytic, and megakaryocytic

A

Acute myelocytic leukemia (AML)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

type of leukemia that includes T cell, B cell, and Null cell

A

Acute lymphocytic leukemia (ALL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

type of leukemia that includes myelocytic and myelomonocytic)

A

Chronic myelocytic leukemia (CML)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

a type of leukemia that includes plasmocytic {multiple myeloma}, Hairy cell, prolymphocytic, large granular cell lymphocytic, Sezary’s syndrome, and circulating lymphoma

A

Chronic lymphocytic leukemia (CLL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

predisposing factors of leukemia (etiology)

A

host factors
environmental factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Some individuals have an _____ to develop leukemia

A

inherited increased predisposition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

There is an increased incidence in those with an ______ or ________ of chromosomes (such as _____).

A

inherited tendency for chromosome fragility or abnormality ; those with increased numbers ; Down’s syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Many of these diseases are characterized by _______.

A

chromosomal translocations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

There is an increased incidence in those with ________.

A

hereditary immunodeficiencies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

There is an increased incidence in those with chronic marrow dysfunction such as those with…

A

myeloproliferative diseases, myelodysplastic syndromes, aplastic anemia, or paroxsymal nocturnal hemoglobinuria.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Environmental factors

A

Exposure to ionizing radiation
Exposure to mutagenic chemicals and drugs
Viral infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

incidence of leukemia

A

Acute leukemias can occur in all age groups
Chronic leukemias are usually a disease of adults

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

ALL is more common in _____

A

children

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

AML is more common in _____

A

adults

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

CLL is extremely rare in ____ and unusual before the age of ___

A

children ; 40

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

CML has a peak age of ____

A

30-50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

acute leukemias on the ff.

Age
Clinical onset
Course (untreated)
Leukemic cells
Anemia
Thrombocytopenia
WBC count
Lymphadenopathy
Splenomegaly

A

Age = all ages
Clinical onset = sudden
Course (untreated) = 6 mos. or less
Leukemic cells = immature >30% blasts
Anemia = prominent
Thrombocytopenia = prominent
WBC count = varibale
Lymphadenopathy = mild
Splenomegaly = mild

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

chronic leukemias on the ff.

Age
Clinical onset
Course (untreated)
Leukemic cells
Anemia
Thrombocytopenia
WBC count
Lymphadenopathy
Splenomegaly

A

Age = usually adults
Clinical onset = insidious
Course (untreated) = 2-6 years
Leukemic cells = more mature cells
Anemia = mild
Thrombocytopenia = mild
WBC count = increased
Lymphadenopathy = present;often prominent
Splenomegaly = present;often prominent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

acute leukemia is a result of malignant transformation of a stem cell leading to _____

A

unregulated proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

acute leukemia is also a result of Arrest in maturation at the ______

A

primitive blast stage (Remember that a blast is the most immature cell that can be recognized as committed to a particular cell line)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

clinical feature: Leukemic proliferation, accumulation, and invasion of normal tissues, including the ____________ cause lesions ranging from rashes to tumors.

A

liver, spleen, lymph nodes, central nervous system, and skin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

clinical feature: A humoral mediator from the leukemic cells may inhibit _______

A

proliferation of normal cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

clinical feature: Failure of the bone marrow and normal hematopoiesis may result in ______

A

pancytopenia with death from hemorrhaging and infections.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

lab diagnosis is based first on,

A

Finding a significant increase in the number of immature cells in the bone marrow including blasts, promyelocytes, promonocytes (>30% blasts is diagnostic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

lab diagnosis is based secondly on,

A

Identification of the cell lineage of the leukemic cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

peripheral blood

A

Anemia (normochromic, normocytic)
Decreased platlets
Variable WBC count

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

The degree of peripheral blood involvement determines classification

A

leukemic
subleukemic
aleukemic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

increased WBCs due to blasts

A

leukemic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

blasts without increased WBCs

A

subleukemic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

decreased WBCs with no blasts

A

aleukemic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Classification of the immature cells involved may be done by

A

Morphology
Immunologic markers (immunophenotyping)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

an experienced morphologist can look at the size of the blast, the amount of cytoplasm, the nuclear chromatin pattern, the presence of nucleoli and the presence of auer rods (are a pink staining, splinter shaped inclusion due to a rod shaped alignment of primary granules found only in myeloproliferative processes) to identify the blast type

A

Morphology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

the myeloblast is a large blast with a moderate amount of cytoplasm, fine lacey chromatin, and prominent nucleoli. 10-40% of myeloblasts contain auer rods.

A

AML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

in contrast to the myeloblast, the lymphoblast is a small blast with scant cytoplasm, dense chromatin, indistinct nucleoli, and no auer rods

A

ALL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

help to classify the lineage of a leukemic cell (myeloid versus lymphoid)

A

Cytochemistry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

found in the primary granules of granulocytic cells starting at the late blast stage. Monocytes may be weakly positive.

A

Myeloperoxidase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

stains phospholipids, neutral fats and sterols found in primary and secondary granules of granulocytic cells and to a lesser extent in monocytic lysosomes. Rare positives occur in lymphoid cells

A

Sudan Black

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

used to identify monocytic cells which are diffusely positive. T lymphocytes may have focal staining

A

Nonspecific esterase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

May be found in myeloblasts and lymphoblasts. T lymphocytes have a high level of ____ and this can be used to help make a diagnosis of acute T-lymphocytic leukemia.

A

acid phosphatase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

located in the secondary granules of segmented neutrophils, bands and metamyelocytes.

A

Leukocyte alkaline phosphatase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Leukocyte alkaline phosphatase score

A

The LAP score is determined by counting 100 mature neutrophils and bands. Each cell is graded from 0 to 5. The total LAP score is calculated by adding up the scores for each cell.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

these are used mainly for lymphocytes, i.e., for determining B cell or T cell lineage. These tests rely on antibodies made against specific surface markers.

A

Immunologic markers (immunophenotyping)

50
Q

Immunologic markers (immunophenotyping) constitute what we would call the ______ and in an indirect assay they are allowed to react with the cells and ______ is then washed away.

A

primary antibody ; unbound antibody

51
Q

______ (secondary antibody) against the primary antibody is added and allowed to react and then _____ is washed away.

A

Fluorescently labeled antibody ; unbound secondary antibody

52
Q

The cells are then sent through a ______ that will determine the _____ of cells that have a fluorescent tag and which are thus positive for the presence of the surface marker to which the primary antibody was made.

A

flow cytometer ; number.

53
Q

In a direct assay, the primary antibody is _______

A

fluorescently labeled.

54
Q

This is a unique DNA polymerase present in stem cells and in precursor B and T lymphoid cells.

A

TERMINAL DEOYXTIDYL TRANSFERASE

55
Q

TERMINAL DEOYXTIDYL TRANSFERASE high levels are found in 90% of _____

A

lymphoblastic leukemias.

56
Q

TERMINAL DEOYXTIDYL TRANSFERASE can also be detected using ______ and ______.

A

appropriate antibodies and flow cytometry

57
Q

a study that can now be used for diagnosis and for prognosis of hematologic malignancies.

A

cytogenetics

58
Q

Many leukemias (and lymphomas) are characterized by specific chromosomal abnormalities, including specific translocations and aneuploidy. The specific type of malignancy can be identified based on the specific abnormality or translocation. These may be identified by

A

Looking at the karyotypes of the chromsomes from the abnormal cells
DNA based tests – these tests are very useful for following the course of the disease
RT-PCR
Southern blotting

59
Q

A ______ is usually associated with a better prognosis.

A

normal karyotype

60
Q

Acute lymphoblastic leukemia may be classified on the basis of the cytological features of the lymphoblasts into;

A

L1
L2
L3

61
Q

This is the most common form found in children and it has the best prognosis.

A

L1

62
Q

in L1, The cell size is ______ with ______ nuclear chromatin and ____ nucleoli.

A

small ; fine or clumped homogenous nuclear chromatin ; absent or indistinct nucleoli

63
Q

in L1, The nuclear shape is ____, occasionally _____ or _____.

A

regular ; clefting or indented

64
Q

in L1, The cytoplasm is _____, with slight to moderate _____ and variable _____.

A

scant ; basophilia ; vacuoles

65
Q

This is the most frequent ALL found in adults.

A

L2

66
Q

in L2, The cell size is ______ and _______ with _____ nuclear chromatin and _____ nucleoli.

A

large and heterogenous ; variable ; prominent

67
Q

in L2, the nucleus is ______, _______ and _____

A

irregular, clefting and indented.

68
Q

in L2, the cytoplasm is ______ and often ______ with variable ______ and variable ______.

A

variable ; moderate to abundant ; basophilia ; vacuoles.

69
Q

This is the rarest form of ALL.

A

L3

70
Q

in L3, the cell size is ____, with ____ homogenous nuclear chromatin containing _____ nucleoli.

A

large ; fine ; prominent

71
Q

in L3, the nucleus is regular ______.

A

oval to round

72
Q

in L3, the cytoplasm is moderately _____ and is deeply _______

A

abundant ; basophilic and vacuolated.

73
Q

ALL may also be classified on the basis of immunologic markers into:

A

Early pre-B ALL
Pre-B ALL
B ALL
T ALL
Null or unclassified ALL (U ALL) - lack B or T markers and may be the committed lymphoid stem cell)

74
Q

ALL is primarily a disease of young children (2-5 years), but it can also occur in adults

A

acute leukemia incidence

75
Q

pancytopenia with resulting fatigue, pallor, fever, weight loss, irritability, anorexia, infection, bleeding, and bone pain.

A

acute leukemia clinical findings

76
Q

L1 occurs in _______, L2 in _____, and L3 is called _____

A

children ; adults ; Burkitts leukemia

77
Q

age, WBC count, and cell type are the most important prognostic indicators

A

acute leukemias prognosis

78
Q

Patients younger than ___ and greater than ___ have a poor prognosis

A

1 ; 13

79
Q

If the WBC count is _____ at presentation, the prognosis is good

A

< 10 x 10^9/L

80
Q

If the WBC count is ______ at presentation the prognosis is poor

A

> 20 x 10^9/L

81
Q

____ ALL (more common in males) has a poorer prognosis than any of the ____ ALLs which have a cure rate of _____

A

T cell ; B cell ; 70%

82
Q

Acute leukemias with mixed lineage – occasionally there are acute leukemias that are biphenotypic and display phenotypes for two different lineages

A

B lymphoid/myeloid
T lymphoid/myeloid
B/T lymphoid
Myeloid/Natural killer
A rare trilineage leukemia has also been seen (was B/T lymphoid/myeloid!)

83
Q

classification of Acute myeloid leukemia depends upon

A

Bone marrow blast morphology
Degree of cell maturation
Cytochemical stains
Immunophenotyping

84
Q

also called acute granulocytic leukemia

A

Acute myeloid leukemia

85
Q

AML is divided into 7 different classifications

A

M1
M2
M3 (M3m)
M4
M5 (M5A, M5B)
M6
M7

86
Q

myeloblastic without maturation

A

M1

87
Q

in M1, the bone marrow shows ___ blasts and ___ promyelocytes

A

≥ 90% ; <10%

88
Q

the disease occurs in older adults

A

M1

89
Q

myeloblastic with maturation

A

M2

90
Q

in M2, The bone marrow shows ____ blasts and ____ promyelocytes

A

30-89% ; > 10%

91
Q

characterized by an 8,21 chromosomal translocation and occurs in older adults

A

M2

92
Q

hypergranular promyelocytic

A

M3

93
Q

This form of AML has a bone marrow with ___ blasts

A

> 30%

94
Q

Is more virulent than other forms

Occurs with a medium age of 39

The WBC count is decreased

It is characterized by a 15,17 chromosomal translocation

A

M3

95
Q

in M3, Treatment causes a release of the ____ and may send the patient into _____ and _____

A

granules ; disseminated intravascular coagulation ; subsequent bleeding

96
Q

hypogranular promyelocytic
The WBC count is increased.
It is characterized by a 15,17 translocation

A

M3M

97
Q

IN M3M, The bone marrow has_____ blasts

A

> 30%

98
Q

Like the M3 type, M3M _____

A

treatment causes a release of the granules and may send the patient into disseminated intravascular coagulation and subsequent bleeding

99
Q

acute myelomonoblastic leukemia

A

M4

100
Q

in m4, Both ______ are seen in the bone marrow and peripheral blood

A

myeloblasts and monoblasts

101
Q

in m4, Infiltration of extramedullary sites is more common than with the _____

A

pure granulocytic variants

102
Q

acute monoblastic leukemia

A

M5

103
Q

in M5, _____ of the nonerythroid cells in the bone marrow are _____

A

> 80% ; monocytic

104
Q

There is extensive infiltration of the gums, CNS, lymph nodes and extramedullary sites, This form is further divided into:

A

M5A
M5B

105
Q

Poorly differentiated (>80% monoblasts)

A

M5A

106
Q

Well differentiated (<80% monoblasts)

A

M5B

107
Q

This is rare and is characterized by a bone marrow having a predominance of erythroblasts

A

M6 – erythroleukemia

108
Q

3 sequentially morphologically defined phases of M6

A

Preponderance of abnormal erythroblasts
Erythroleukemia – there is an increase in both erythroblasts and myeloblasts
Myeloblastic leukemia – M1, M2, or M4

109
Q

in M6, anemia is common (Yes or No)

A

Yes

110
Q

This is a rare disorder characterized by extensive proliferation of megakaryoblasts, atypical megakaryocytes and thrombocytopenia

A

M7 - Acute megkaryoblastic leukemia

111
Q

2 goals of leukemia treatment

A

Eradicate the leukemic cell mass
Give supportive care

112
Q

Except for ALL in children, cures are not common but ______ is.

A

complete remission (absence of any leukemia related signs and symptoms and return of bone marrow and peripheral blood values to within normal values)

113
Q

There are four general types of therapy

A

Chemotherapy
Bone Marrow Transplant
Radiotherapy
Immunotherapy
Monoclonal antibodies

114
Q

usually a combination of drugs is used

A

chemotherapy

115
Q

stimulate the patients own immune system to mount a response against the malignant cells

A

immunotherapy

116
Q

examples include Rituxin

A

monoclonal antibodies

117
Q

WHO CLASSIFICATION includes different biologically distinct groups based on:

A

clinical features
cytogenetic and molecular abnormalities
morphology

118
Q

a major difference between WHO and FAB classification is the blasts cut-off for a diagnosis of AML:

A

20% - WHO
30 % - FAB

119
Q

AML with blasts 20 – 30 % by WHO can benefit from therapies for ________ that were approved by USFDA

A

MYELODYSPASIA

120
Q

are neoplastic proliferative diseases that are characterized by an overproduction of immature and mature cells of various leucocyte types in the Bone Marrow and/or peripheral blood

A

leukemia

121
Q

characterize by
a. symptoms of short duration
b. many immature cell forms in the Bone marrow and/or peripheral blood
c. elevated leucocyte count

A

acute leukemia

122
Q

characterize by
a. symptoms of long duration
b. mostly mature cell forms in the Bone marrow and/or peripheral blood
c. total leucocyte counts that range from extremely elevated to less than normal

A

chronic leukemia